Yuli Xie

786 total citations
26 papers, 486 citations indexed

About

Yuli Xie is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Yuli Xie has authored 26 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Organic Chemistry. Recurrent topics in Yuli Xie's work include Protein Tyrosine Phosphatases (3 papers), Galectins and Cancer Biology (3 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Yuli Xie is often cited by papers focused on Protein Tyrosine Phosphatases (3 papers), Galectins and Cancer Biology (3 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Yuli Xie collaborates with scholars based in United States, China and Italy. Yuli Xie's co-authors include Donald W. Landry, Shi‐Xian Deng, Fengxia Tian, Jin Zhang, Jianjun Hu, Shi-Du Yan, Gangli Gong, Renjun Pei, Tan Wang and Milan N. Stojanović and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Pain.

In The Last Decade

Yuli Xie

26 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuli Xie United States 14 241 150 74 49 48 26 486
Kathleen A. Merkler United States 15 382 1.6× 46 0.3× 42 0.6× 43 0.9× 52 1.1× 20 630
Damien Habrant France 11 220 0.9× 211 1.4× 18 0.2× 32 0.7× 36 0.8× 14 526
Abdul Hameed Khan Pakistan 12 304 1.3× 225 1.5× 36 0.5× 13 0.3× 58 1.2× 27 661
Dominique Lesuisse France 16 370 1.5× 336 2.2× 38 0.5× 27 0.6× 36 0.8× 38 745
Efrosini Barbayianni Greece 16 470 2.0× 152 1.0× 9 0.1× 28 0.6× 42 0.9× 25 659
Brigitte D’Arcy Switzerland 9 431 1.8× 38 0.3× 28 0.4× 32 0.7× 87 1.8× 9 584
Elizabeth K. Hendrickson United States 11 317 1.3× 55 0.4× 18 0.2× 22 0.4× 67 1.4× 15 526
Katsunori Tsuboi Japan 12 335 1.4× 296 2.0× 18 0.2× 31 0.6× 14 0.3× 18 686
Sumiko Tanaka Japan 11 148 0.6× 58 0.4× 35 0.5× 40 0.8× 13 0.3× 21 395
Esther Marco Spain 15 342 1.4× 225 1.5× 15 0.2× 14 0.3× 22 0.5× 28 789

Countries citing papers authored by Yuli Xie

Since Specialization
Citations

This map shows the geographic impact of Yuli Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuli Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuli Xie more than expected).

Fields of papers citing papers by Yuli Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuli Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuli Xie. The network helps show where Yuli Xie may publish in the future.

Co-authorship network of co-authors of Yuli Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yuli Xie. A scholar is included among the top collaborators of Yuli Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuli Xie. Yuli Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Yuli, Xiang Wang, Shengzhu Huang, et al.. (2025). Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer. Communications Biology. 8(1). 696–696. 5 indexed citations
2.
Zhou, Rongbin, Hong Chen, Yuli Xie, et al.. (2025). SPP1 as a biomarker for idiopathic membranous nephropathy progression and its regulatory role in inflammation and fibrosis. Frontiers in Immunology. 16. 1671891–1671891. 1 indexed citations
3.
Huang, Rong, Mengying Bao, Yan Dai, et al.. (2024). Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer. Journal of Translational Medicine. 22(1). 48–48. 16 indexed citations
4.
Zhang, Qingyun, et al.. (2024). Single cell RNA-Sequencing Reveals Mast Cells Enhance Mononuclear Phagocytes Infiltration in Bladder Cancer Microenvironment. Journal of Cancer. 15(17). 5672–5690. 3 indexed citations
5.
Xie, Yuli, et al.. (2023). Novel homozygous mutations in TXNDC15 causing Meckel syndrome. Molecular Genetics & Genomic Medicine. 12(3). e2343–e2343. 3 indexed citations
6.
Xie, Yuli, et al.. (2022). Compound heterozygous mutations in PMFBP1 cause acephalic spermatozoa syndrome: A case report. World Journal of Clinical Cases. 10(34). 12761–12767. 7 indexed citations
7.
Tian, Fengxia, Tan Wang, Yuli Xie, Jin Zhang, & Jianjun Hu. (2015). Genome-Wide Identification, Classification, and Expression Analysis of 14-3-3 Gene Family in Populus. PLoS ONE. 10(4). e0123225–e0123225. 48 indexed citations
8.
Tian, Fengxia, et al.. (2015). Aldehyde Dehydrogenase Gene Superfamily in Populus: Organization and Expression Divergence between Paralogous Gene Pairs. PLoS ONE. 10(4). e0124669–e0124669. 25 indexed citations
10.
Vidović, D., Yuli Xie, Donald W. Landry, et al.. (2011). Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype. Journal of Computer-Aided Molecular Design. 25(9). 873–883. 1 indexed citations
11.
Pei, Renjun, et al.. (2009). Light-up properties of complexes between thiazole orange-small molecule conjugates and aptamers. Nucleic Acids Research. 37(8). e59–e59. 40 indexed citations
12.
Cremona, María Laura, Yidong Liu, Yuli Xie, et al.. (2009). Potent inhibitors of Huntingtin protein aggregation in a cell-based assay. Bioorganic & Medicinal Chemistry Letters. 19(6). 1715–1717. 8 indexed citations
13.
Xie, Yuli, Yidong Liu, Gangli Gong, et al.. (2009). Small-Molecule Modulators of the NF-κB Pathway Newly Identified by a Translocation-Based Cellular Assay. Current Topics in Medicinal Chemistry. 9(13). 1172–1180. 2 indexed citations
14.
Xie, Yuli, Yidong Liu, Gangli Gong, et al.. (2008). Discovery of potent non-urea inhibitors of soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry Letters. 19(8). 2354–2359. 24 indexed citations
15.
Raffo, Anthony J., Kolbe Hancock, Yuli Xie, et al.. (2008). Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. Journal of Endocrinology. 198(1). 41–49. 36 indexed citations
16.
Xie, Yuli, Yidong Liu, Gangli Gong, et al.. (2008). Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase. Bioorganic & Medicinal Chemistry Letters. 18(9). 2840–2844. 33 indexed citations
17.
Xie, Yuli, Anthony J. Raffo, Masanori Ichise, et al.. (2008). Novel hypoglycemic dihydropyridones serendipitously discovered from O- versus C-alkylation in the synthesis of VMAT2 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 5111–5114. 13 indexed citations
18.
Xie, Yuli, et al.. (2006). Identification of small-molecule inhibitors of the Aβ–ABAD interaction. Bioorganic & Medicinal Chemistry Letters. 16(17). 4657–4660. 56 indexed citations
19.
Xie, Yuli, Hua‐Sheng Ding, Lihui Qian, et al.. (2005). Synthesis and biological evaluation of novel bisphosphonates with dual activities on bone in vitro. Bioorganic & Medicinal Chemistry Letters. 15(13). 3267–3270. 13 indexed citations
20.
Tam, Iris W., et al.. (2003). A Forbidden Rearrangement. Organic Letters. 5(19). 3407–3409. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026